AIM · AIM ImmunoTech Inc.

Summary

AIM ImmunoTech Inc. completed its rights offering on March 6, 2026, selling 1,842 units consisting of 1,842 shares of Series G Convertible Preferred Stock and 3,684,000 Class G Warrants for gross proceeds of approximately $1,800,000. The company entered into a Warrant Agency Agreement with Equiniti Trust Company, LLC and filed a Certificate of Designation for the Series G Preferred Stock on March 4, 2026.

Key takeaways

• Rights Offering closed March 6, 2026 with 1,842 units sold
• Each unit includes 1 share Series G Preferred Stock ($1,000 stated value, convertible at $1.00/share) and 2,000 Class G Warrants
• 3,684,000 Class G Warrants issued, exercisable at $1.00/share, expire March 6, 2031
• Gross proceeds approximately $1,800,000
• Warrant Agency Agreement with Equiniti Trust Company, LLC
• Certificate of Designation filed March 4, 2026 for 12,000 shares Series G Preferred Stock